We’re proud to announce the successful completion of the Ministry of Health inspection of the Republic of Kazakhstan at Lambda’s Ahmedabad facility from October 1-3, 2024. This is another strong validation of our processes and our proactive approach to regulatory compliance and quality-driven execution.
This achievement underscores Lambda Therapeutic Research’s role as a trusted partner in clinical research, providing reliable, high-quality services across different regulatory environments and geographies.
About Lambda
Lambda & Novum delivers comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide. With a strong global presence in India, the USA, Canada, the UK, Spain and Poland, we bring specialized expertise to every project. Our focus on secure IT infrastructure and automation ensures timely project delivery and strict adherence to international regulatory standards. Lambda’s exemplary regulatory track record includes over 60 successful inspections and audits by esteemed authorities, including the USFDA, EMEA, MHRA, EU member states, and other global regulatory bodies, in the past five years.
Lambda’s commitment to excellence has garnered significant recognition, including the ‘Best Indian CRO’ award from Frost & Sullivan (USA) and the ‘Great Indian Workplace’ title from UBS Transformance. Recent accolades include the ‘Regulatory Excellence’ Award at the CPhI Pharma Awards 2023 and the ‘Industry Partner of the Year’ Award at the Global Generics & Biosimilar Awards 2023.
